Results 111 to 120 of about 13,720 (213)
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides [PDF]
, 2014 Diagnosis of heart failure (HF) is not based on a single test, but on a combination of history, physical examination and appropriate investigations. For these reasons, the accuracy of diagnosis by clinical means alone is often inadequate, especially in ...
A. Clerico +3 more
core +1 more source
Вестник трансплантологии и искусственных органов, 2017 Aim. To perform comparative analysis of the diagnostic efficacy of sCD40L, PDGF-BB, VEGF-A and ST2 in recipients with cardiac rejection in different periods after transplantation. Materials and methods. The study included 144 cardiac recipients aged from
O. P. Shevchenko +7 more
doaj +1 more source
Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening [PDF]
, 2014 Background: Currently available screening tools for left ventricular (LV) hypertrophy (LVH) and systolic dysfunction (LVSD) are either expensive (echocardiography) or perform suboptimally (B‐type natriuretic peptide [BNP]).
Aragam, Jayashri +13 more
core +1 more source
Development of a Novel Heart Failure Risk Tool : The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator) [PDF]
, 2014 Background: A combination of clinical and routine laboratory data with biomarkers reflecting different pathophysiological pathways may help to refine risk stratification in heart failure (HF).
Agustín Urrutia +8 more
core +4 more sources
On Quantum Special Kaehler Geometry
, 2009 We compute the effective black hole potential V of the most general N=2, d=4 (local) special Kaehler geometry with quantum perturbative corrections, consistent with axion-shift Peccei-Quinn symmetry and with cubic leading order behavior. We determine the
ALESSIO MARRANI +26 more
core +1 more source
Indian Heart Journal, 2018 Cardiovascular diseases are leading cause of mortality and morbidity, and are responsible for 1 out of every 6 deaths in the United States.1 Cardiac remodeling is an important determinant of long term outcomes and occurrence of heart failure (HF).
Aditi Dattagupta, Sathyamurthy Immaneni
doaj +1 more source
Peripartum cardiomyopathy: an update [PDF]
, 1991 Purpose of Review Peripartum cardiomyopathy (PPCM) is an idiopathic disorder defined as heart failure occurring in women during the last month of pregnancy and up to 5 months postpartum.
Azibani, Feriel, Sliwa-Hahnle, Karen
core +6 more sources
IL-33/ST2 Axis in Organ Fibrosis
Frontiers in Immunology, 2018 Interleukin 33 (IL-33) is highly expressed in barrier sites, acting via the suppression of tumorigenicity 2 receptor (ST2). IL-33/ST2 axis has long been known to play a pivotal role in immunity and cell homeostasis by promoting wound healing and tissue ...
Ourania S. Kotsiou +4 more
doaj +1 more source
Soluble ST2 – biomarker for prognosis and monitoring in decompensated heart failure
Kardiologiia, 2019 The review aims to appraise the value of determining the concentrations of the new biomarker sST2 for assessing prognosis and monitoring treatment effectiveness of patients with decompensated heart failure during an episode of decompensation and during long-term follow-up after discharge from the hospital.
A A, Skvortsov +2 more
openaire +3 more sources